AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Price, Quote, News and Overview
NASDAQ:AMPH - Nasdaq - US03209R1032 - Common Stock - Currency: USD
AMPH Quote, Performance and Key Statistics
AMPHASTAR PHARMACEUTICALS IN
NASDAQ:AMPH (1/31/2025, 4:30:00 PM)
After market: 34.87 0 (0%)34.87
-1.5 (-4.12%)
The current stock price of AMPH is 34.87 USD. In the past month the price decreased by -6.09%. In the past year, price decreased by -33.96%.
AMPH Latest News, Press Releases and Analysis
Investors should take notice of NASDAQ:AMPH—it offers a great deal for the fundamentals it presents.
AMPHASTAR PHARMACEUTICALS IN has caught the attention as a great value stock. NASDAQ:AMPH excels in profitability, solvency, and liquidity, all while being very reasonably priced.
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
Amphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January.
AMPH Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 79.75 | 769.97B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.43 | 375.07B | ||
| JNJ | JOHNSON & JOHNSON | 15.23 | 366.32B | ||
| MRK | MERCK & CO. INC. | 16.61 | 249.98B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.57 | 219.43B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.04 | 209.36B | ||
| PFE | PFIZER INC | 10.28 | 150.29B | ||
| SNY | SANOFI-ADR | 14.85 | 136.24B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.38 | 119.56B | ||
| ZTS | ZOETIS INC | 29.67 | 77.10B | ||
| GSK | GSK PLC-SPON ADR | 8.5 | 71.96B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.32 | 42.45B |
Related stock screener links
About AMPH
Company Profile
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. The company is headquartered in Rancho Cucamonga, California and currently employs 1,761 full-time employees. The company went IPO on 2014-06-25. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. Its segments include finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes Primatene MIST, epinephrine, glucagon, phytonadione, lidocaine, enoxaparin, naloxone, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API for external customers and internal product development. Its pipeline has over 20 product candidates, including generic ANDAs, biosimilar, and others.
Company Info
AMPHASTAR PHARMACEUTICALS IN
11570 6th St
Rancho Cucamonga CALIFORNIA 91730 US
CEO: Jack Y. Zhang
Employees: 1761
Company Website: https://amphastar.com/
Investor Relations: https://ir.amphastar.com/
Phone: 19099809484
AMPH FAQ
What is the stock price of AMPH?
The current stock price of AMPH is 34.87 USD.
What is the symbol for AMPHASTAR PHARMACEUTICALS IN stock?
The exchange symbol of AMPHASTAR PHARMACEUTICALS IN is AMPH and it is listed on the Nasdaq exchange.
On which exchange is AMPH stock listed?
AMPH stock is listed on the Nasdaq exchange.
Is AMPH a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for AMPH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of AMPH.
Does AMPH stock pay dividends?
AMPH does not pay a dividend.
What is the Price/Earnings (PE) ratio of AMPH?
The PE ratio for AMPH is 9.13. This is based on the reported non-GAAP earnings per share of 3.82 and the current share price of 34.87 USD.
What is the Short Interest ratio of AMPH stock?
The outstanding short interest for AMPH is 12.83% of its float.
AMPH Technical Analysis
AMPH Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to AMPH. AMPH has an excellent profitability rating, but there are some minor concerns on its financial health.
AMPH Financial Highlights
Over the last trailing twelve months AMPH reported a non-GAAP Earnings per Share(EPS) of 3.82. The EPS decreased by 21.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 21.8% | ||
| ROA | 10.21% | ||
| ROE | 21.67% | ||
| Debt/Equity | 0.82 |
AMPH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to AMPH. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 20.24% and a revenue growth 14.94% for AMPH